• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Search Orphan Drug Designations and Approvals

  • Print
  • Share
  • E-mail
Generic Name: flunarizine
Date Designated: 05/12/2021
Orphan Designation: Treatment of Childhood Absence Epilepsy
Orphan Designation Status: Designated
FDA Orphan Approval Status: Not FDA Approved for Orphan Indication
Xenon Pharmaceuticals Inc.
200-3650 Gilmore Way
Burnaby, BC V5G 4W8

The sponsor address listed is the last reported by the sponsor to OOPD.

*Exclusivity Protected Indications are shown for approvals from Jan. 1, 2013, to the present.